{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:24:03Z","timestamp":1790396643378,"version":"4.1.0"},"reference-count":50,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2016.0377","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:27:14Z","timestamp":1525238834000},"source":"Crossref","is-referenced-by-count":43,"title":["The Diagnosis and Treatment of Hair and Scalp Diseases"],"prefix":"10.3238","author":[{"given":"Hans","family":"Wolff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias W.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Blume-Peytavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2016,5,27]]},"reference":[{"key":"10.3238\/arztebl.2016.0377_ref1","doi-asserted-by":"crossref","unstructured":"Cash T: The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol 1999; 141: 398\u2013405","DOI":"10.1046\/j.1365-2133.1999.03030.x"},{"key":"10.3238\/arztebl.2016.0377_ref2","doi-asserted-by":"crossref","unstructured":"Paus R, Cotsarelis G: The biology of hair follicles. N Engl J Med 1999; 341: 491\u20137","DOI":"10.1056\/NEJM199908123410706"},{"key":"10.3238\/arztebl.2016.0377_ref3","doi-asserted-by":"crossref","unstructured":"Courtois M, Loussouarn G, Hourseau S, Grollier JF: Periodicity in the growth and shedding of hair. Br J Dermatol 1996; 134: 47\u201354","DOI":"10.1111\/j.1365-2133.1996.tb07839.x"},{"key":"10.3238\/arztebl.2016.0377_ref4","doi-asserted-by":"crossref","unstructured":"Lindner J, Hillmann K, Blume-Peytavi U, et al.: Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography. Br J Dermatol 2012; 167: 1272\u20138","DOI":"10.1111\/j.1365-2133.2012.11180.x"},{"key":"10.3238\/arztebl.2016.0377_ref5","doi-asserted-by":"crossref","unstructured":"Ross EK, Vincenzi C, Tosti A: Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol 2006; 55: 799\u2013806","DOI":"10.1016\/j.jaad.2006.04.058"},{"key":"10.3238\/arztebl.2016.0377_ref6","doi-asserted-by":"crossref","unstructured":"Whiting DA: Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 1996; 35: 899\u2013906","DOI":"10.1016\/S0190-9622(96)90113-9"},{"key":"10.3238\/arztebl.2016.0377_ref7","doi-asserted-by":"crossref","unstructured":"Kantor J, Kessler LJ, Brooks DG, Cotsarelis G: Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003; 121: 985\u20138","DOI":"10.1046\/j.1523-1747.2003.12540.x"},{"key":"10.3238\/arztebl.2016.0377_ref8","doi-asserted-by":"crossref","unstructured":"Blume-Peytavi U, Blumeyer A, Tosti A, et al.: S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol 2011; 164: 5\u201315","DOI":"10.1111\/j.1365-2133.2010.10011.x"},{"key":"10.3238\/arztebl.2016.0377_ref9","doi-asserted-by":"crossref","unstructured":"Heilmann S, Brockschmidt FF, Hillmer AM, et al.: Evidence for a polygenic contribution to androgenetic alopecia. Br J Dermatol 2013; 169: 927\u201330","DOI":"10.1111\/bjd.12443"},{"key":"10.3238\/arztebl.2016.0377_ref10","doi-asserted-by":"crossref","unstructured":"The Finasteride Male Pattern Hair Loss Study Group: Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002; 12: 38\u201349","DOI":"10.33589\/12.3.0129"},{"key":"10.3238\/arztebl.2016.0377_ref11","doi-asserted-by":"crossref","unstructured":"Blume-Peytavi U, Vogt A: Current standards in the diagnostics and therapy of hair diseases\u2014hair consultation. J Dtsch Dermatol Ges 2011; 9: 394\u2013410","DOI":"10.1111\/j.1610-0387.2011.07609.x"},{"key":"10.3238\/arztebl.2016.0377_ref12","doi-asserted-by":"crossref","unstructured":"Blumeyer A, Tosti A, Messenger A, et al.: Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 2011; 9 (Suppl 6): 1\u201357","DOI":"10.1111\/j.1610-0379.2011.07802.x"},{"key":"10.3238\/arztebl.2016.0377_ref13","doi-asserted-by":"crossref","unstructured":"Lucky AW, Piacquadio DJ, Ditre CM, et al.: A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 2004; 50: 541\u201353","DOI":"10.1016\/j.jaad.2003.06.014"},{"key":"10.3238\/arztebl.2016.0377_ref14","doi-asserted-by":"crossref","unstructured":"van Zuuren EJ, Fedorowicz Z, Carter B: Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review. Br J Dermatol 2012; 167: 995\u20131010","DOI":"10.1111\/j.1365-2133.2012.11166.x"},{"key":"10.3238\/arztebl.2016.0377_ref15","doi-asserted-by":"crossref","unstructured":"Olsen EA, Dunlap FE, Funicella T, et al.: A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002; 47: 377\u201385","DOI":"10.1067\/mjd.2002.124088"},{"key":"10.3238\/arztebl.2016.0377_ref16","doi-asserted-by":"crossref","unstructured":"Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G: Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol 2010; 146: 1141\u201350","DOI":"10.1001\/archdermatol.2010.256"},{"key":"10.3238\/arztebl.2016.0377_ref17","doi-asserted-by":"crossref","unstructured":"Price V, Roberts JL, Hordinsky M: Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000; 43: 768\u201376","DOI":"10.1067\/mjd.2000.107953"},{"key":"10.3238\/arztebl.2016.0377_ref18","doi-asserted-by":"crossref","unstructured":"Gubelin Harcha W, Barboza Martinez J, Tsai TF, et al.: A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol 2014; 70: 489\u201398","DOI":"10.1016\/j.jaad.2013.10.049"},{"key":"10.3238\/arztebl.2016.0377_ref19","doi-asserted-by":"crossref","unstructured":"Sinclair R, Wewerinke M, Jolley D: Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol 2005; 152: 466\u201373","DOI":"10.1111\/j.1365-2133.2005.06218.x"},{"key":"10.3238\/arztebl.2016.0377_ref20","doi-asserted-by":"crossref","unstructured":"Freyschmidt-Paul P, Happle R, Hoffmann R: Alopecia areata. Klinik, Pathogenese und rationale Therapie einer T-Zell-vermittelten Autoimmunerkrankung. Hautarzt 2003; 54: 713\u201322","DOI":"10.1007\/s00105-003-0560-z"},{"key":"10.3238\/arztebl.2016.0377_ref21","doi-asserted-by":"crossref","unstructured":"Tosti A, Bellavista S, Iorizzo M: Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 2006; 55: 438\u201341","DOI":"10.1016\/j.jaad.2006.05.008"},{"key":"10.3238\/arztebl.2016.0377_ref22","doi-asserted-by":"crossref","unstructured":"Gilhar A, Etzioni A, Paus R: Alopecia areata. N Engl J Med 2012; 366: 1515\u201325","DOI":"10.1056\/NEJMra1103442"},{"key":"10.3238\/arztebl.2016.0377_ref23","doi-asserted-by":"crossref","unstructured":"Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M: British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012. Br J Dermatol 2012; 166: 916\u201326","DOI":"10.1111\/j.1365-2133.2012.10955.x"},{"key":"10.3238\/arztebl.2016.0377_ref24","doi-asserted-by":"crossref","unstructured":"Tosti A, Iorizzo M, Botta GL, Milani M: Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol 2006; 20: 1243\u20137","DOI":"10.1111\/j.1468-3083.2006.01781.x"},{"key":"10.3238\/arztebl.2016.0377_ref25","doi-asserted-by":"crossref","unstructured":"Fischer TW: Alopezien \u2013 Diagnostisches und therapeutisches Management. Akt Dermatol 2008; 34: 209\u201325","DOI":"10.1055\/s-2007-995795"},{"key":"10.3238\/arztebl.2016.0377_ref26","doi-asserted-by":"crossref","unstructured":"Tr\u00fceb RM: Vernarbende Alopezien. Hautarzt 2013; 64: 810\u20139","DOI":"10.1007\/s00105-013-2577-2"},{"key":"10.3238\/arztebl.2016.0377_ref27","doi-asserted-by":"crossref","unstructured":"Powell JJ, Dawber RPR, Gatter K: Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol 1999; 140: 328\u201333","DOI":"10.1046\/j.1365-2133.1999.02675.x"},{"key":"10.3238\/arztebl.2016.0377_ref28","doi-asserted-by":"crossref","unstructured":"Stockmeier M, Kunte C, Feldmann KA, Messer G, Wolff H: Folliculitis decalvans \u2013 Behandlung mit einer systemischen Rifampicin-Clindamycin-Kombinationstherapie bei 17 Patienten. Akt Dermatol 2001; 27: 361\u20133","DOI":"10.1055\/s-2001-19129"},{"key":"10.3238\/arztebl.2016.0377_ref29","doi-asserted-by":"crossref","unstructured":"Bolz S, Jappe U, Hartschuh W: Successful treatment of perifolliculitis capitis abscedens et suffodiens with combined isotretinoin and dapsone. J Dtsch Dermatol Ges 2008; 6: 44\u20137","DOI":"10.1111\/j.1610-0387.2007.06399_supp.x"},{"key":"10.3238\/arztebl.2016.0377_ref30","doi-asserted-by":"crossref","unstructured":"Scerri L, Williams HC, Allen BR: Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol 1996; 134: 1105\u20138","DOI":"10.1111\/j.1365-2133.1996.tb07952.x"},{"key":"10.3238\/arztebl.2016.0377_ref31","doi-asserted-by":"crossref","unstructured":"Le Cleach L, Chosidow O: Clinical practice. Lichen planus. N Engl J Med 2012; 366: 723\u201332","DOI":"10.1056\/NEJMcp1103641"},{"key":"10.3238\/arztebl.2016.0377_ref32","doi-asserted-by":"crossref","unstructured":"Kossard S: Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol 1994; 130: 770\u20134","DOI":"10.1001\/archderm.130.6.770"},{"key":"10.3238\/arztebl.2016.0377_ref33","doi-asserted-by":"crossref","unstructured":"Vano-Galvan S, Molina-Ruiz AM, Serrano-Falcon C, et al.: Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol 2014; 70: 670\u20138","DOI":"10.1016\/j.jaad.2014.01.376"},{"key":"10.3238\/arztebl.2016.0377_ref34","doi-asserted-by":"crossref","unstructured":"Manousaridis I, Manousaridis K, Peitsch WK, Schneider SW: Individualisierte Behandlung und Therapiewahl bei Lichen planus: ein schrittweiser Ansatz. J Dtsch Dermatol Ges 2013: 981\u201391","DOI":"10.1111\/ddg.12141"},{"key":"10.3238\/arztebl.2016.0377_ref35","doi-asserted-by":"crossref","unstructured":"Racz E, Gho C, Moorman PW, Noordhoek Hegt V, Neumann HA: Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review. J Eur Acad Dermatol Venereol 2013; 27: 1461\u201370","DOI":"10.1111\/jdv.12139"},{"key":"10.3238\/arztebl.2016.0377_ref36","doi-asserted-by":"crossref","unstructured":"Harries MJ, Messenger A: Treatment of frontal fibrosing alopecia and lichen planopilaris. J Eur Acad Dermatol Venereol 2014; 28: 1404\u20135","DOI":"10.1111\/jdv.12362"},{"key":"10.3238\/arztebl.2016.0377_ref37","doi-asserted-by":"crossref","unstructured":"Sinclair R: Diffuse hair loss. Int J Dermatol 1999; 38 (Suppl 1): 8\u201318","DOI":"10.1046\/j.1365-4362.1999.00003.x"},{"key":"10.3238\/arztebl.2016.0377_ref38","doi-asserted-by":"crossref","unstructured":"Apsner R, Horl WH, Sunder-Plassmann G: Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation. Blood 2001; 97: 2914\u20135","DOI":"10.1182\/blood.V97.9.2914"},{"key":"10.3238\/arztebl.2016.0377_ref39","doi-asserted-by":"crossref","unstructured":"Wilsmann-Theis D, Bieber T: Psoriasis und Ekzeme am Capillitum. Hautarzt 2014; 65: 1043\u20139","DOI":"10.1007\/s00105-014-3542-4"},{"key":"10.3238\/arztebl.2016.0377_ref40","doi-asserted-by":"crossref","unstructured":"Tr\u00fceb RM: Systematisches Vorgehen bei Frauen mit Haaarausfall. JDDG 2010; 8: 284\u201398","DOI":"10.1111\/j.1610-0387.2010.07261_supp.x"},{"key":"10.3238\/arztebl.2016.0377_ref41","doi-asserted-by":"crossref","unstructured":"Hoffmann R: TrichoScan, a GCP-validated tool to measure hair growth. J Eur Acad Dermatol Venereol 2008; 22: 132\u20134","DOI":"10.1111\/j.1468-3083.2007.02470.x"},{"key":"10.3238\/arztebl.2016.0377_ref42","doi-asserted-by":"crossref","unstructured":"Hillmer AM, Brockschmidt FF, Hanneken S, et al.: Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 2008; 40: 1279\u201381.","DOI":"10.1038\/ng.228"},{"key":"10.3238\/arztebl.2016.0377_ref43","doi-asserted-by":"crossref","unstructured":"Redler S, Dobson K, Drichel D, et al.: Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss. J Dermatol Sci 2013; 72: 186\u20138","DOI":"10.1016\/j.jdermsci.2013.06.012"},{"key":"10.3238\/arztebl.2016.0377_ref44","doi-asserted-by":"crossref","unstructured":"Yim E, Nole KL, Tosti A: 5-alpha-Reductase inhibitors in androgenetic alopecia. Curr Opin Endocrinol Diabetes Obes 2014; 21: 493\u20138","DOI":"10.1097\/MED.0000000000000112"},{"key":"10.3238\/arztebl.2016.0377_ref45","doi-asserted-by":"crossref","unstructured":"Betz RC, Petukhova L, Ripke S, et al.: Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun 2015; 6: 5966","DOI":"10.1038\/ncomms6966"},{"key":"10.3238\/arztebl.2016.0377_ref46","unstructured":"Peter C, Hoting E: Therapie der Alopecia areata mit Zinksulfat \u2013 eine placebokontrollierte Studie an 307 Patienten. Z Hautkr 1996; 71: 175\u201389."},{"key":"10.3238\/arztebl.2016.0377_ref47","doi-asserted-by":"crossref","unstructured":"Xing L, Dai Z, Jabbari A, et al.: Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med 2014; 20: 1043\u20139","DOI":"10.1038\/nm.3645"},{"key":"10.3238\/arztebl.2016.0377_ref48","doi-asserted-by":"crossref","unstructured":"Headington JT: Transverse microscopic anatomy of the human scalp. Arch Dermatol 1984; 120: 449\u201356","DOI":"10.1001\/archderm.120.4.449"},{"key":"10.3238\/arztebl.2016.0377_ref49","doi-asserted-by":"crossref","unstructured":"Kunte C, Loeser C, Wolff H: Folliculitis spinulosa decalvans: successful therapy with dapsone. J Am Acad Dermatol 1998; 39: 891\u20133","DOI":"10.1016\/S0190-9622(98)70374-3"},{"key":"10.3238\/arztebl.2016.0377_ref50","doi-asserted-by":"crossref","unstructured":"Tan E, Martinka M, Ball N, Shapiro J: Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol 2004; 50: 25\u201332","DOI":"10.1016\/j.jaad.2003.04.001"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T08:34:27Z","timestamp":1638779667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,27]]},"references-count":50,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2016.0377","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1007\/s12634-017-5387-1","asserted-by":"object"},{"id-type":"doi","id":"10.1007\/s40257-017-0297-6","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,27]]}}}